RxDoctor Payments Data

Ramegowda Rajagopal, MD

Cardiovascular Disease · Detroit, MINPI 1538131511

Payments from drug & device makers

$504in general payments, 2019–2025

Across 14 payments — averaging $36.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$287
  • Vanda Pharmaceuticals Inc.$101
  • GE HealthCare$37
  • Lantheus Medical Imaging, Inc.$23
  • Lilly USA, LLC$17
  • Amarin Pharma, Inc.$14
  • plus $26 from 2 others

What the payments were for

  • Food & beverage$21743%
  • Education$28757%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$504 in reported general payments places this provider in the 20th percentile of 760 cardiovascular disease providers in Michigan.

See all cardiovascular disease providers in Michigan

Medicare billing

Part B allowed, 2024
$2,504
Medicare patients
24
Services billed
30

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →